Kraig Biocraft Laboratories Further Expands Spider Silk Production Levels with Launch of Third Production Cycle
Kraig Biocraft Laboratories (OTCQB: KBLB) has launched its third and largest production cycle of spider silk for 2024. This expanded cycle, released in scheduled batches, aims to address the rainy season peak while driving towards 2024 production volume goals. The company has brought an additional production facility online to support increased silkworm rearing and silk production.
Kraig Labs expects to add more facilities over the next two months, supporting its goal of delivering the first metric ton of spider silk to global markets. Each production cycle further validates the company's spider silk production model and demonstrates its specialized silkworms' readiness for mass production. The company's CEO, Kim Thompson, described 2024 as an inflection point for spider silk commercialization.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha avviato il suo terzo e più grande ciclo di produzione di seta di ragno per il 2024. Questo ciclo espanso, rilasciato in lotti programmati, mira a soddisfare il picco della stagione delle piogge mentre punta agli obiettivi di volume di produzione del 2024. L'azienda ha messo in funzione un ulteriore impianto di produzione per supportare l'allevamento di bachi da seta e la produzione di seta.
Kraig Labs prevede di aggiungere ulteriori impianti nei prossimi due mesi, a sostegno del suo obiettivo di fornire la prima tonnellata metrica di seta di ragno ai mercati globali. Ogni ciclo di produzione convalida ulteriormente il modello di produzione di seta di ragno dell'azienda e dimostra la prontezza dei suoi bachi da seta specializzati per la produzione di massa. Il CEO dell'azienda, Kim Thompson, ha descritto il 2024 come un punto di svolta per la commercializzazione della seta di ragno.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha lanzado su terciclo de producción más grande de seda de araña para 2024. Este ciclo ampliado, lanzado en lotes programados, tiene como objetivo abordar el pico de la temporada de lluvias mientras avanza hacia los objetivos de volumen de producción de 2024. La compañía ha puesto en marcha una instalación de producción adicional para soportar el aumento de la cría de gusanos de seda y la producción de seda.
Kraig Labs espera agregar más instalaciones en los próximos dos meses, apoyando su objetivo de entregar la primera tonelada métrica de seda de araña a los mercados globales. Cada ciclo de producción valida aún más el modelo de producción de seda de araña de la compañía y demuestra la preparación de sus gusanos de seda especializados para la producción en masa. La CEO de la empresa, Kim Thompson, describió 2024 como un punto de inflexión para la comercialización de la seda de araña.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 2024년을 위한 세 번째이자 가장 큰 거미줄 생산 주기를 시작했습니다. 이 확대된 주기는 예정된 배치로 출시되며, 비가 오는 시즌의 정점을 타겟팅하고 동시에 2024년 생산량 목표를 향해 나아가는 것을 목표로 하고 있습니다. 회사는 증가하는 누에 기르기와 실크 생산을 지원하기 위해 추가 생산 시설을 가동했습니다.
Kraig Labs는 향후 2개월 이내에 추가 시설을 추가할 계획으로, 이는 전 세계 시장에 첫 번째 메트릭 톤의 거미줄을 전달할 목표를 지원합니다. 각 생산 주기는 회사의 거미줄 생산 모델을 더욱 검증하며, 특수한 누에가 대량 생산에 준비되어 있음을 보여줍니다. 회사의 CEO인 킴 톰슨은 2024년을 거미줄 상업화의 전환점으로 묘사했습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a lancé son troisième et plus grand cycle de production de soie d'araignée pour 2024. Ce cycle élargi, publié en lots programmés, vise à répondre au pic de la saison des pluies tout en avançant vers les objectifs de volume de production de 2024. L'entreprise a mis en ligne une installation de production supplémentaire pour soutenir l'élevage accru de vers à soie et la production de soie.
Kraig Labs prévoit d'ajouter d'autres installations au cours des deux prochains mois, soutenant son objectif de livrer la première tonne métrique de soie d'araignée sur les marchés mondiaux. Chaque cycle de production valide davantage le modèle de production de soie d'araignée de l'entreprise et démontre la préparation de ses vers à soie spécialisés à la production de masse. Le PDG de l'entreprise, Kim Thompson, a décrit 2024 comme un point de basculement pour la commercialisation de la soie d'araignée.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat seinen dritten und größten Produktionszyklus von Spinnenseide für 2024 gestartet. Dieser erweiterte Zyklus, der in geplanten Chargen veröffentlicht wird, zielt darauf ab, den Höhepunkt der Regenzeit zu berücksichtigen und gleichzeitig auf die Produktionsziele für 2024 hinzuarbeiten. Das Unternehmen hat eine zusätzliche Produktionsstätte in Betrieb genommen, um die Aufzucht von Seidenraupen und die Seidenproduktion zu unterstützen.
Kraig Labs plant, in den nächsten zwei Monaten weitere Einrichtungen hinzuzufügen, um sein Ziel zu unterstützen, die erste metrische Tonne Spinnenseide an die globalen Märkte zu liefern. Jeder Produktionszyklus validiert weiter das Produktionsmodell der Spinnenseide des Unternehmens und zeigt die Bereitschaft seiner spezialisierten Seidenraupen für die Massenproduktion. Der CEO des Unternehmens, Kim Thompson, bezeichnete das Jahr 2024 als Wendepunkt für die Kommerzialisierung von Spinnenseide.
- Launched third and largest production cycle of 2024
- Additional production facility brought online to expand capacity
- Plans to add more facilities in the next two months
- Aiming to deliver first metric ton of spider silk to global markets
- Validating spider silk production model for mass production
- None.
ANN ARBOR, Mich., July 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces the launch of its third and largest production cycle of the 2024 spider silk production season.
This cycle is being released in a set of scheduled batches, the first of which is already in production. This batch process is designed to address the upcoming peak of the rainy season while driving Kraig Labs toward its 2024 production volume goals.
This expanded production cycle was empowered by an additional production facility recently brought online. The Company is utilizing this newly constructed facility to support the continued expansion of silkworm rearing and silk production, avoiding the typical slowdowns due to rain.
Kraig Labs expects to bring additional facilities online over the next two months to increase its production footprint in support of its goal of delivering the first metric ton of spider silk to the global markets.
With each successive production cycle, the Company further validates its spider silk production model and that its specialized silkworms are ready for mass production. This now-fielded technology has broken through technical barriers, allowing for the large-scale commercial production of engineered spider silk using the cost-effective, time-tested, and established infrastructure for traditional silk.
"Our rearing operations continue to set new commercial spider silk production records. The first half of 2024 was a game-changer for the commercialization of spider silk, and we are expecting even greater things for the second half of the year," said Company Founder and CEO, Kim Thompson. "This year has been an inflection point for Kraig Labs and for the limitless possibilities of spider silk commercialization."
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
FAQ
What is Kraig Biocraft Laboratories' latest production milestone for spider silk in 2024?
How is Kraig Biocraft Laboratories (KBLB) expanding its spider silk production capacity?
What is Kraig Biocraft Laboratories' (KBLB) production goal for spider silk?
How does Kraig Biocraft Laboratories (KBLB) produce spider silk commercially?
